Drug Transporter (DT) Information

General Information of DT
DT ID DTD0056
Gene Name ABCC10
Protein Name Multidrug resistance-associated protein 7
Gene ID
89845
UniProt ID
Q5T3U5
TCDB ID
3.A.1.208.31
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 5UJ9_A

Identity: 34.882%

Minimized Score: -2035.798 kcal/mol

Detail: Structure Info

Synonyms ATP-binding cassette sub-family C member 10; ABCC10; MRP7; SIMRP7
DT Family ATP-Binding Cassette (ABC) Superfamily
Drug Conjugate Transporter (DCT) Family (ABCC)
Tissue Specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed.
Function This ATP-dependent transporter probably involved in cellular detoxification through lipophilic anion extrusion.
Disease(s) Human immunodeficiency virus infection [ICD-11: 1C62.Z]
Endogenous Substrate(s) Lipophilic anions
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT
Microbiota Influence (MBI)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(α) Mutation-induced Structural Variation
Mutation-induced Structural Variation (MSV)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

(γ) Outward/inward-facing Conformation
Outward/inward-facing Conformation (OIC)

(δ) Xenobiotics-regulated Structural Variability
Xenobiotics-regulated Structural Variability (XSV)

General Variability Data of This DT (VARIDT 1.0)

(α) Genetic Polymorphisms of This DT
Genetic Polymorphisms of This DT (GPD)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:            4 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Docetaxel
 Approved Drug Info Lung cancer 2C25 [1]
Paclitaxel
 Approved Drug Info Breast cancer 2C60-2C6Z [1]
Tamoxifen
 Approved Drug Info Breast cancer 2C60-2C6Z [1]
Tenofovir
 Approved Drug Info Human immunodeficiency virus infection 1C62.Z [2]

Endogenous Metabolites (EMs) Handled by This DT

 Endogenous Metabolites (EMs)

 Click to Show/Hide the Full List of EMs:            1 EMs in Total
EM Name PubChem CID Detail Experimental Material Ref
Estradiol-17beta-glucuronide
5281887
EM Info Unclear experiment used for identifying this EM [3]

Drug-DT Affinity Assessed by Cell Line

 Approved Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Tamoxifen Approved Drug Info LLC-PK1 cells-MRP7 Km = 0.078 microM [1]
References
1 Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7). Cancer Res. 2012 Dec 15;72(24):6457-67.
2 Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction. J Infect Dis. 2011 Jul 1;204(1):145-53.
3 Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr Med Chem. 2008;15(20):1981-2039.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.